# Interest of Positive Expiratory Pressure (PEP) Delivery by EzPAP® After Cardiac Surgery in the Management of Postoperative Atelectasis

> **NCT02262182** · NA · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 80 (actual)

## Conditions studied

- Pulmonary Atelectasis

## Interventions

- **OTHER:** KP group
- **OTHER:** KM group

## Key facts

- **NCT ID:** NCT02262182
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2016-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02262182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02262182, "Interest of Positive Expiratory Pressure (PEP) Delivery by EzPAP® After Cardiac Surgery in the Management of Postoperative Atelectasis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02262182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*